We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
Unitil
UTL
$973M
| $1K | ﹤0.01% |
20
-21
| -51% | -$1.05K |
2016 Q4
19 quarters
|
|
2952
Veritone
VERI
$56.4M
| $1K | ﹤0.01% |
+26
| New | +$530 |
2021 Q3
0 quarters
|
|
2953
Vanda Pharmaceuticals
VNDA
$256M
| $1K | ﹤0.01% |
+46
| New | +$806 |
2021 Q3
0 quarters
|
|
2954
Vor Biopharma
VOR
$1.14B
| $1K | ﹤0.01% |
4
+2
| +100% | +$595 |
2021 Q2
1 quarter
|
|
|
VRE
2955
DELISTED
Veris Residential
VRE
| $1K | ﹤0.01% |
68
| – | – |
2020 Q3
4 quarters
|
|
2956
Vroom Inc
VRM
$46.3M
| – | – |
0
| – | – |
2021 Q2
1 quarter
|
|
2957
DELISTED
Vital Energy
VTLE
| $1K | ﹤0.01% |
+8
| New | +$489 |
2021 Q3
0 quarters
|
|
2958
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$123M
| $1K | ﹤0.01% |
+3
| New | +$1.34K |
2021 Q3
0 quarters
|
|
2959
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$460M
| $1K | ﹤0.01% |
27
+1
| +4% | +$57 |
2020 Q3
4 quarters
|
|
2960
Warner Music
WMG
$16.1B
| $1K | ﹤0.01% |
+16
| New | +$608 |
2021 Q3
0 quarters
|
|
2961
Westport Fuel Systems
WPRT
$34.6M
| $1K | ﹤0.01% |
37
+27
| +270% | +$1.09K |
2019 Q3
8 quarters
|
|
2962
Wolverine World Wide
WWW
$1.64B
| $1K | ﹤0.01% |
27
-168
| -86% | -$5.73K |
2021 Q1
2 quarters
|
|
2963
XP
XP
$15.2B
| $1K | ﹤0.01% |
21
| – | – |
2020 Q3
4 quarters
|
|
2964
Xerox
XRX
$352M
| $1K | ﹤0.01% |
57
-52
| -48% | -$1.18K |
2016 Q4
19 quarters
|
|
2965
Oruka Therapeutics
ORKA
$4.89B
| $1K | ﹤0.01% |
+20
| New | +$739 |
2021 Q3
0 quarters
|
|
2966
JBT Marel
JBTM
$5.5B
| $1K | ﹤0.01% |
5
| – | – |
2021 Q1
2 quarters
|
|
2967
Tvardi Therapeutics
TVRD
$14.3M
| $1K | ﹤0.01% |
1
| – | – |
2018 Q2
13 quarters
|
|
2968
Tutor Perini Cor
TPC
$4.13B
| $1K | ﹤0.01% |
43
| – | – |
2021 Q1
2 quarters
|
|
2969
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1K | ﹤0.01% |
23
+11
| +92% | +$570 |
2021 Q1
2 quarters
|
|
2970
DELISTED
VOXX International Corporation Class A
VOXX
| $1K | ﹤0.01% |
+56
| New | +$640 |
2021 Q3
0 quarters
|
|
2971
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1K | ﹤0.01% |
60
-50
| -45% | -$1.21K |
2021 Q2
1 quarter
|
|
2972
DELISTED
Vector Group Ltd.
VGR
| $1K | ﹤0.01% |
121
| – | – |
2016 Q4
19 quarters
|
|
2973
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
| $1K | ﹤0.01% |
151
| – | – |
2021 Q2
1 quarter
|
|
2974
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1K | ﹤0.01% |
11
+7
| +175% | +$738 |
2020 Q4
3 quarters
|
|
2975
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
| $1K | ﹤0.01% |
+666
| New | +$1.53K |
2021 Q3
0 quarters
|
|
Similar funds
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.